ENIGMA-Epilepsy Logo

About the ENIGMA Consortium

The ENIGMA Consortium is an international effort by leaders worldwide. The Consortium brings together researchers in imaging genomics, neurology and psychiatry, to understand brain structure and function, based on MRI, DTI, fMRI, genetic data and many patient populations.

ENIGMA Consortium Logo

ENIGMA-Epilepsy Mission

As the ENIGMA Epilepsy Working Group, we are dedicated to improving our understanding of in vivo neuroanatomical disruptions in people with epilepsy compared to healthy individuals in the general population. The consortium's co-chairs include Professor Sisodiya (UCL, UK), and Professor Carrie McDonald (UCSD, USA).

Consortium activities

Here are some typical activities underway by the consortium:

  • Data submission: MRI data and demographic/clinical covariates are submitted to central processing (UCSD) for data processing, analysis and harmonization.
  • Secondary Proposals: Project leads submit a written project proposal and work with UCSD central processing (for collated derived MRI metrics and covariate data) and co-authors (for study design and manuscript content) to execute analysis and develop a manuscript of results.
  • Weekly meeting: Co-chairs (UCSD, UCL) hold a weekly meeting tracking projects and project management. Sites provide guest presentations as required.
  • Quarterly meeting: Teleconference with all ENIGMA-Epilepsy members providing news and status updates on secondary proposals, conference presentations and manuscript progress.
  • Conference meetings: We try to gather for a social meeting at popular conferences such as Organization for Human Brain Mapping (OHBM), American Epilepsy Society (AES) etc.
  • Mail list: We have a mail list for sending out communications to the consortium, mainly invites to the quarterly meetings. If you would like to join the mail list email sehatton@health.ucsd.edu.

Research Areas

enigma_publications_2023
Title Lead Published Link
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study Whelan CD 1-Feb-18 10.1093/brain/awx341
The ENIGMA-Epilepsy working group: Mapping disease from large data sets. Sisodiya SM 29-May-20 10.1002/hbm.25037
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study Hatton SN 1-Aug-20 10.1093/brain/awaa200
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study Larivière S 18-Nov-20 10.1126/sciadv.abc6457
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study Gleichgerrcht E 24-Jul-21 10.1016/j.nicl.2021.102765
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies Altmann A 22-Feb-26 10.1111/nan.12758
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy Park BY 24-May-22 10.1093/brain/awab417
Structural network alterations in focal and generalized epilepsy assessed in a worldwide ENIGMA study follow axes of epilepsy risk gene expression. Larivière S 27-Jul-22 10.1038/s41467-022-31730-5
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data Lopez SM 22-Aug-26 10.1111/epi.17316
Patterns of subregional cerebellar atrophy across epilepsy syndromes: An ENIGMA-Epilepsy study Kerestes R 24-Apr-26 10.1111/epi.17881
A Worldwide ENIGMA Study on Epilepsy-Related Gray and White Matter Compromise Across the Adult Lifespan Chen J 23-Sep-25 10.1212/WNL.0000000000213688
Associations between epilepsy-related polygenic risk and brain morphology in childhood Ngo A 7-Feb-26 10.1093/brain/awaf259
Abnormal functional connectivity patterns in temporal lobe epilepsy-An international ENIGMA-epilepsy study Ives-Deliperi V 25-Mar-26 10.1002/epi4.70209

Sites

We collaborate with a wide range of world leading research groups and clinical centers around the world. All these sites have shared MRI data and demographic/clinical covariates with the consortium. Sites of note:

Current statistics on ENIGMA: Dynamic ENIGMA-Epilepsy Summary Dashboard Current ENIGMA-Epilepsy sites

Site Code Site Alias Full name Country Leads
1 NIH, Bethesda, MD (US) National Institute of Health USA Leigh Sepeta; Sara Inati
2 UniMoRe (IT) Universita' di Modena e Reggio Emilia Italy Stefano Meletti; Anna Vaudano
3 UDA (IT) Universita' D'Annunzio Italy Stefano Sensi
4 Rush, Chicago, IL (US) Rush University Medical Center USA Travis Stoub
5 UniCa (IT) Universita ' di Cagliari Italy Luca Saba
6 USZ, Zurich (CH) University Hospital Zurich Switzerland Marian Galovic
7 UNICAMP, Campinas (BR) Universidade Estadual de Campinas Brazil Fernando Cendes
8 GWU, Washington, DC (USA) George Washington University USA Taha Gholipour
9 UCT, Cape Town (SA) University of Cape Town South Africa Victoria Ives-Deliperi
10 CN, Nanjing University of Nanjing China Zhiqiang Zhang
11 UCSD, La Jolla, CA (US) University of California San Diego USA Carrie McDonald/Erik Kaestner
12 ULB (Bruxelles, BE) Université Libre de Bruxelles Belgium Chantal Depondt
13 EPICZ (IT) University of Catanzaro Italy Antonio Gambardella
14 FSM, IRCCS (IT) Fondazione IRCCS Stella Maris Italy Emanuele Bartolini
15 Göttingen (DE) University of Göttingen Germany Niels Focke
16 UKBonn, Bonn (DE) University Hospital Bonn Germany Theodor Rueber
17 MNI, Montreal, QC (CA) Montreal Neurological Institute, McGill University Canada Boris Bernhardt
18 NYU, New York, NY (US) New York University USA Orrin Devinsky/Heath Pardoe
19 IGG (IT) University of Genova Italy Pasquale Stariano
20 UNAM, Mexico City (MX) Universidad Nacional Autónoma de México Mexico Luis Concha
21 UCLA, Los Angeles, CA (US) University of California Los Angeles USA Richard Staba
22 UPenn, Philadelphia, PA (US) University of Pennsylvania USA Kathryn A. Davis
23 MUSC, Columbia, SC (US) Medical University of South Carolina USA Ezequiel Gleichgerrcht
24 LNF IRCCS (IT) IRCCS Medea - La Nostra Famiglia di Conegliano Italy Paolo Bonanni
25 Emory, Atlanta, GA (US) Emory University USA Ezequiel Gleichgerrcht/Leo Bonilha
26 Meyer Clinic, Florence (IT) Meyer Clinic Florence Italy Renzo Guerrini
27 Tübingen (DE) University of Tübingen Germany Pascal Martin
28 UCL (Univ College London), London (UK) University College London UK Sanjay Sisodiya/Patrick B Moloney; John Duncan
29 Monash at Alfred Institute, Melbourne (AU) Alfred Institute at Monash University Australia Terence J. O’Brien
30 UniMe, Messina (IT) @ Palermo University of Messina Italy Angelo Labate
31 UCSF, San Francisco, CA (US) University of California San Francisco USA Jon Kleen
32 Frankfurt, Frankfurt (DE) Frankfurt University Germany Johann Philipp
33 UWO, London, Ontario (CA) University of Western Ontario Canada Giovanni Pellegrino
34 UCalgary, Calgary, Alberta (CA) University of Calgary Canada Paolo Federico
35 TLVMC, Tel Aviv (IL) Tel Aviv Medical Center Israel Firas Fahoum
36 Mass General Brigham (MGB) Mass General Brigham USA John Rolston
37 Henry Ford, Detroit, MI (US) Henry Ford Health System USA Hamid Soltanian-Zadeh
38 CHUV, Lausanne (CH) Lausanne University Hospital Switzerland Carolina Ciumas
39 QU Queens University Canada Gavin Winston
NA USC, Los Angles (USA) University of Southern California USA Paul M. Thompson

Secondary Proposals

Secondary Proposals are where sites can propose and conduct analysis of the ENIGMA-Epilepsy data. The secondary proposals process is:

  1. An investigator submits a Secondary Proposal (available from sehatton@health.ucsd.edu) detailing the outline of the proposed study.
  2. The Secondary Proposal may be presented to the consortium during the quarterly teleconference. The proposal is circulated to the consortium members for review.
  3. An electronic form is circulated to the consortium requesting participation in site data sharing (i.e. authorizing site data inclusion in the specific proposal) and contributing to study design and manuscript development.
  4. After the data cutoff, MRI derivatives, demographic and clinical data is collated at the central processing site (UCSD) and sent to the Secondary Proposal lead for analysis.
  5. When results are ready, the Secondary Proposal is typically presented to the consortium at the quarterly teleconference for discussion.
  6. Manuscript undergoes internal review with participating consortium members that signed up to the Secondary Proposal.
  7. Central processing (UCSD, USC) helps submit the manuscript for external review (e.g. help with large author blocks, affiliations etc.).
  8. Publication or resubmission.

Systems Overview

MRI Processing Pipeline Architecture

The ENIGMA-Epilepsy team have developed a Python-based orchestration framework for neuroimaging data analysis, LOCIPipe. The pipeline features BIDS-compliable, containerized pipelines for extracting the following data (Figure 1):

Preprocessing:

  • MRIQC: Extracting IQM from raw MRI data. https://mriqc.readthedocs.io/
  • QSIPrep: Automatically generated DWI preprocessing pipelines that will group, distortion correct, motion correct, denoise, coregister and resample scans. https://qsiprep.readthedocs.io/
  • fMRIPrep: A functional MRI (fMRI) data preprocessing pipeline that performs basic processing steps (coregistration, normalization, unwarping, noise component extraction, segmentation, skull-stripping, etc.). https://fmriprep.org/

Processing:

  • FreeSurfer: Segments and parcellates T1-weighted structural MRIs into anatomical models of the human brain. https://surfer.nmr.mgh.harvard.edu/
  • CAT12: Automated pipeline that extracts both volumetric (voxel-level) and surface-level neuroanatomy directly from a T1-weighted MRI. This pipeline also includes a QC report. https://neuro-jena.github.io/cat/
  • QSIRecon: Takes the QSIPrep DWI preprocessing and produces outputs such as ODF/FOD reconstruction, model fits and parameter estimation, regional connectivity, and tractography (i.e. pyAFQ tractography). https://qsirecon.readthedocs.io/

Postprocessing:

ENIGMA-Epilepsy LOCIPipeline Architecture

Figure 1. ENIGMA-Epilepsy LOCIPipeline Architecture

Demographic and clinical covariate management

Site-level demographic and clinical covariate are centrally managed using REDCap (Research Electronic Data Capture), a secure, web-based software platform designed to build and manage online databases and surveys.

Submitting Data to the ENIGMA-Epilepsy Consortium

Data Use Agreement and Memorandum of Understanding

Prior to the transfer of data, the site is required to complete a Data Use Agreement (DUA). Each person that will be handling ENIGMA-Epilepsy Consortium data needs to complete a Memorandum of Understanding (MOU). Forms are available from sehatton@health.ucsd.edu.

Preparing MRI data

MRI data is to be provided as DICOMs (e.g. one subject/session per folder) or NIFTI with JSON sidecar. If you are converting from DICOMs to NIFTI/JSONs we recommend using either dcm2bids or BIDScoin. We are HIPAA, GDPR, and GCP compliant: please anonymize to remove identifying header information (dates, names, addresses etc.). MRI data does not need to be defaced as we are not publicly sharing raw MRI data.

If you have field maps, during the anonymization process please ensure these header fields are recorded in the JSON:

  • IntendedFor: E.g. "IntendedFor": ["bids::sub-01/ses-01/dwi/sub-01_ses-01_dir-AP_dwi.nii.gz"]
  • B0FieldIdentifier & B0FieldSource: E.g. "B0FieldIdentifier": "fmap_run01", "B0FieldSource": "fmap_run01"
  • TotalReadoutTime: If using EPI files for fieldmap correction, ensure they have "TotalReadoutTime", e.g.: "TotalReadoutTime": 0.00475.
  • PhaseEncodingDirection: For EPI, ASL, fMRI-BOLD, and DWI images, ensure they have the "PhaseEncodingDirection" field, e.g.: "PhaseEncodingDirection": "j-"

Preparing demographic and clinical covariates

The full data dictionary of demographic and clinical covariates is available as a PDF for reference. A shortened Word document version is also available which lists the core covariates that must be included for participation in secondary projects. The covariate file can be submitted as a CSV or Excel file.

Data transfer method

Data (MRI and demographic/clinical covariate information) are transferred via box.com. When you are ready, send an email to sehatton@health.ucsd.edu and you will be provided with a link to drag-and-drop the data in.

Contact